Reduced phagocytosis of heat-aggregated human IgG by polymorphonuclear leucocytes from patients with systemic lupus erythematosus
Ikebe, K.; Okawa, M.; Aotsuka, S.; Yokohari, R.
Ryumachi 20(2): 75-81
1980
ISSN/ISBN: 0300-9157 PMID: 7384948 Document Number: 168289
Document emailed within 1 workday
Related Documents
Fyfe, A.; Holme, E.R.; Zoma, A.; Whaley, K. 1987: C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus Clinical and Experimental Immunology 67(2): 300-308Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Yeaman, G.R.; Kerr, M.A. 1987: Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes Clinical and Experimental Immunology 68(1): 200-208
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Yoshida, K.; Yukiyama, Y.; Miyamoto, T. 1987: Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus Journal of Rheumatology 14(3): 490-496
Diumenjo, M.S.; Rivero, I.; Vannucci, J.D. 1978: Nonspecific defense mechanism in systemic lupus erythematosus: phagocytosis, adherence and leukocyte peroxidase Revista Clinica Espanola 148(3): 273-277
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Shingu, M.; Hurd, E.R. 1981: Sera from patients with systemic lupus erythematosus reactive with human endothelial cells Journal of Rheumatology 8(4): 581-586
Horwitz, D.A.; Juul-Nielsen, K. 1977: Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells Clinical and Experimental Immunology 30(3): 370-378
Leong, K.P.; Tee, N.W.; Yap, W.M.; Chee, T.S.; Koh, E.T. 2000: Nocardiosis in patients with systemic lupus erythematosus. the Singapore Lupus Study Group Journal of Rheumatology 27(5): 1306-1312
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Timeskov, I.S.; Chirkina, S.S.; Dolgobvorova, K.F.; Gil'fanov, R.N.; Zhuravleva, S.I. 1979: Evaluation of work capacity of patients with systemic lupus erythematosus and systemic scleroderma Terapevticheskii Arkhiv 51(1): 68-71
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Bugrova, O.V.; Kutyrina, I.M.; Bagirova, V.V.; Morozova, E.V.; Gromova, M.M. 2001: Effects of acute pharmacological blockade of the renin-angiotensin system on intrarenal hemodynamics in patients with systemic lupus erythematosus and systemic scleroderma Terapevticheskii Arkhiv 73(6): 20-25
Kaneko, N.; Masuyama, J-Ichi.; Nara, H.; Hirata, D.; Iwamoto, M.; Okazaki, H.; Minota, S.; Yoshio, T. 2002: Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis Journal of Rheumatology 29(10): 2106-2113
Nowicka-Sauer, K.; Czuszynska, Z.; Smolenska, Z.; Siebert, J. 2011: Neuropsychological assessment in systemic lupus erythematosus patients: clinical usefulness of first-choice diagnostic tests in detecting cognitive impairment and preliminary diagnosis of neuropsychiatric lupus Clinical and Experimental Rheumatology 29(2): 299-306
Byrd, V.M.; Sergent, J.S. 1996: Suppression of systemic lupus erythematosus by the human immunodeficiency virus Journal of Rheumatology 23(7): 1295-1296
Witt, C.; Apostoloff, E.; Müller, G.M.; Buchali, K.; Hiepe, F.; Brenke, A.; Romberg, B.; Winsel, K. 1992: Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus Pneumologie 46(1): 20-25